Development of Medical Countermeasures for Biothreat Agents, Antimicrobial-Resistant Infections an Emerging Infectious Diseases
Award Notice Posted
- Solicitation number
- HHS-NIH-NIAID-BAA2021-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Immunartes, LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93022C00057 Federal contract award
Notice details come from SAM.gov. Updated .
About this opportunity
Immunartes LLC was awarded a cost-reimbursement contract valued at $10,403,420 by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases on September 21, 2022 to develop medical countermeasures for biothreat agents, antimicrobial-resistant infections and emerging infectious diseases over an unspecified period of performance. The contract was awarded under a full and open competition solicitation posted on September 28, 2022 with no set-aside designation.
Notice text
This cost-reimbursement contract award was made under full and open competition.
Awarded contract 75N93022C00057 to Immunartes LLC for 10403420.00 on 2022-09-21.
Notice history
6 of 9 notices listed here. See the rest on GovTribe.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity